BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29572636)

  • 1. Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
    Thust SC; Hassanein S; Bisdas S; Rees JH; Hyare H; Maynard JA; Brandner S; Tur C; Jäger HR; Yousry TA; Mancini L
    Eur Radiol; 2018 Sep; 28(9):3779-3788. PubMed ID: 29572636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient.
    Maynard J; Okuchi S; Wastling S; Busaidi AA; Almossawi O; Mbatha W; Brandner S; Jaunmuktane Z; Koc AM; Mancini L; Jäger R; Thust S
    Radiology; 2020 Jul; 296(1):111-121. PubMed ID: 32315266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
    Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
    J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional and Volumetric Parameters for Diffusion-Weighted WHO Grade II and III Glioma Genotyping: A Method Comparison.
    Thust SC; Maynard JA; Benenati M; Wastling SJ; Mancini L; Jaunmuktane Z; Brandner S; Jäger HR
    AJNR Am J Neuroradiol; 2021 Mar; 42(3):441-447. PubMed ID: 33414227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent Diffusion Coefficient as Imaging Biomarker for Identifying IDH Mutation, 1p19q Codeletion, and MGMT Promoter Methylation Status in Patients With Glioma.
    Ma X; Cheng K; Cheng G; Li C; Lyu J; Lan Y; Duan C; Bian X; Zhang J; Lou X
    J Magn Reson Imaging; 2023 Sep; 58(3):732-738. PubMed ID: 36594577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas.
    Wu CC; Jain R; Radmanesh A; Poisson LM; Guo WY; Zagzag D; Snuderl M; Placantonakis DG; Golfinos J; Chi AS
    AJNR Am J Neuroradiol; 2018 Oct; 39(10):1814-1820. PubMed ID: 30190259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping.
    Lewis MA; Ganeshan B; Barnes A; Bisdas S; Jaunmuktane Z; Brandner S; Endozo R; Groves A; Thust SC
    Eur J Radiol; 2019 Apr; 113():116-123. PubMed ID: 30927935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apparent Diffusion Coefficient Histogram Analysis:Differentiation of Genetic Subtypes of Diffuse Lower-grade Gliomas].
    Liu D; Xu JM; Liao HF; Wen M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Aug; 42(4):444-451. PubMed ID: 32895095
    [No Abstract]   [Full Text] [Related]  

  • 11. A Comparative Study of 2 Different Segmentation Methods of ADC Histogram for Differentiation Genetic Subtypes in Lower-Grade Diffuse Gliomas.
    Liu D; Gao SX; Liao HF; Xu JM; Wen M
    Biomed Res Int; 2020; 2020():9549361. PubMed ID: 33062706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.
    Villanueva-Meyer JE; Wood MD; Choi BS; Mabray MC; Butowski NA; Tihan T; Cha S
    AJR Am J Roentgenol; 2018 Mar; 210(3):621-628. PubMed ID: 29261348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.
    Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U
    Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Between Apparent Diffusion Coefficient and the Ki-67 Proliferation Index in Grading Pediatric Glioma.
    Yao R; Cheng A; Zhang Z; Jin B; Yu H
    J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):322-328. PubMed ID: 36957971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient measurement in glioma: Influence of region-of-interest determination methods on apparent diffusion coefficient values, interobserver variability, time efficiency, and diagnostic ability.
    Han X; Suo S; Sun Y; Zu J; Qu J; Zhou Y; Chen Z; Xu J
    J Magn Reson Imaging; 2017 Mar; 45(3):722-730. PubMed ID: 27527072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging.
    Liu S; Zhang Y; Kong Z; Jiang C; Wang Y; Zhao D; You H; Ma W; Feng F
    BMC Neurosci; 2022 Dec; 23(1):72. PubMed ID: 36471242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index.
    She Y; Liu X; Jiang J; Wang X; Niu Q; Zhou J
    Acta Radiol; 2024 May; 65(5):489-498. PubMed ID: 38644751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Subtype Classification in Lower-Grade Glioma with Accelerated DTI.
    Aliotta E; Nourzadeh H; Batchala PP; Schiff D; Lopes MB; Druzgal JT; Mukherjee S; Patel SH
    AJNR Am J Neuroradiol; 2019 Sep; 40(9):1458-1463. PubMed ID: 31413006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion-weighted MRI models.
    Guo H; Liu J; Hu J; Zhang H; Zhao W; Gao M; Zhang Y; Yang G; Cui Y
    J Magn Reson Imaging; 2022 Dec; 56(6):1834-1844. PubMed ID: 35488516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.